Find Drugs for Infections and Infectious Diseases in Phase II Clinical Development in CHINA

Lead Product(s): TNP-2092

Therapeutic Area: Infections and Infectious Diseases

Highest Development Status: Phase II Product Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 20, 2020

Details:

TenNor has completed a Phase II clinical trial for TNP-2092 in the United States for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and received positive results.